Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anaplastic large cell lymphoma, ALK-positive in very young children: A long-term follow-up of two cases and a review of the literature.

The Malaysian journal of pathology·2023
Same author

Longitudinal Flow Decorrelations in Xe+Xe Collisions at sqrt[s_{NN}]=5.44  TeV with the ATLAS Detector.

Physical review letters·2021
Same author

Search for Heavy Resonances Decaying into a Photon and a Hadronically Decaying Higgs Boson in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2021
Same author

Search for Higgs Boson Decays into a Z Boson and a Light Hadronically Decaying Resonance Using 13 TeV pp Collision Data from the ATLAS Detector.

Physical review letters·2020
Same author

Dijet Resonance Search with Weak Supervision Using sqrt[s]=13  TeV pp Collisions in the ATLAS Detector.

Physical review letters·2020
Same author

CP Properties of Higgs Boson Interactions with Top Quarks in the tt[over ¯]H and tH Processes Using H→γγ with the ATLAS Detector.

Physical review letters·2020

Related Experiment Video

Updated: Jun 28, 2026

Synthesis and Assay of Vibrio Quorum Sensing Inhibitors
03:29

Synthesis and Assay of Vibrio Quorum Sensing Inhibitors

Published on: May 31, 2024

In vitro toxicological properties of thymoquinone.

M Khader1, N Bresgen, P M Eckl

  • 1Division of Genetics, Department of Cell Biology, University of Salzburg, Hellbrunnerstrasse 34, A-5020 Salzburg, Austria.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|November 18, 2008
PubMed
Summary

Thymoquinone, a compound from Nigella sativa, shows significant cytotoxic and genotoxic effects in rat liver cells. These findings challenge previous notions of its protective properties, suggesting potential toxicity at higher concentrations.

Related Experiment Videos

Last Updated: Jun 28, 2026

Synthesis and Assay of Vibrio Quorum Sensing Inhibitors
03:29

Synthesis and Assay of Vibrio Quorum Sensing Inhibitors

Published on: May 31, 2024

Area of Science:

  • Pharmacology
  • Toxicology
  • Hepatology

Background:

  • Nigella sativa and its constituent thymoquinone are traditionally used for inflammation, liver disorders, and arthritis.
  • Experimental studies suggest antioxidant, anti-inflammatory, and hepato-protective properties of thymoquinone.
  • Further toxicological evaluation in a cellular system is needed.

Purpose of the Study:

  • To evaluate the cytotoxic and genotoxic effects of thymoquinone in primary rat hepatocyte cultures.
  • To determine the concentration-dependent effects of thymoquinone on cell viability and DNA integrity.

Main Methods:

  • Primary rat hepatocytes were treated with varying concentrations of thymoquinone.
  • Cytotoxicity was assessed by measuring mitotic indices, apoptosis, and necrosis rates.
  • Genotoxicity was evaluated by analyzing chromosomal aberrations and micronucleated cells.

Main Results:

  • Thymoquinone exhibited concentration-dependent cytotoxic effects, including anti-proliferative activity at 20 microM and acute cytotoxicity at higher concentrations.
  • Significant increases in necrotic cell rates were observed between 2.5 and 20 microM.
  • Genotoxicity was induced at concentrations greater than or equal to 1.25 microM.
  • These results contradict previous reports of antioxidant and anti-clastogenic effects.

Conclusions:

  • Thymoquinone demonstrates significant cyto- and genotoxic effects in rat hepatocytes, challenging its purported protective roles.
  • The compound may be metabolized into reactive species, leading to oxidative stress, glutathione depletion, and DNA damage.
  • These findings highlight potential risks associated with high thymoquinone concentrations and warrant further investigation.